Drug data last refreshed 10h ago · AI intelligence enriched 2w ago
ACTIFED W/ CODEINE is an oral syrup combining antihistamine and decongestant components with codeine, a centrally-acting cough suppressant. The product is indicated for symptomatic relief of upper respiratory congestion and cough. It is a small-molecule fixed-dose combination targeting multi-symptom cold and allergy relief.
Early-stage launch preparation offers opportunity to build brand foundation and establish market positioning in competitive OTC/behind-counter cold and cough category.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
ACTIFED W/ CODEINE is a pre-launch product offering entry or transition opportunities in OTC/controlled substance commercial strategy with GSK. Career progression will depend on successful market entry execution and navigating regulatory constraints around opioid-containing products.
Worked on ACTIFED W/ CODEINE at GSK? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.